Last checked at 16 Jul 2018 08:53
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Date: 11 JULY 2018
Name of applicant: | ALLERGY THERAPEUTICS PLC | |||
Name of scheme: | Allergy Therapeutics plc 2013 Long Term Incentive Plan | |||
Period of return: | From: | 21 Nov 2017 | To: | 11 July 2018 |
Balance of unallotted securities under scheme(s) from previous return: | 10,000,000 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | - | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 2,050,848
| |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 7,949,152
| |||
Name of contact: | Sara Goldsbrough |
Telephone number of contact: | +44 (0) 7966 165719 |
Total Voting Rights
The total number of voting rights of the company is 596,168,616. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify an interest in, or a change to their interest in, the share capital of the company under the FCA's Disclosure and Transparency Rules.